CN114533633A - Phellinus baumii fermentation product and preparation method thereof - Google Patents
Phellinus baumii fermentation product and preparation method thereof Download PDFInfo
- Publication number
- CN114533633A CN114533633A CN202210049427.5A CN202210049427A CN114533633A CN 114533633 A CN114533633 A CN 114533633A CN 202210049427 A CN202210049427 A CN 202210049427A CN 114533633 A CN114533633 A CN 114533633A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- phellinus baumii
- phellinus
- baumii
- potato
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 93
- 230000004151 fermentation Effects 0.000 title claims abstract description 93
- 241001556385 Sanghuangporus baumii Species 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000000047 product Substances 0.000 claims abstract description 50
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 43
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 43
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 5
- 230000003213 activating effect Effects 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 241000123107 Phellinus Species 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 239000011049 pearl Substances 0.000 abstract description 46
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 24
- 239000002537 cosmetic Substances 0.000 abstract description 10
- 230000002087 whitening effect Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 239000006071 cream Substances 0.000 abstract description 3
- 239000000839 emulsion Substances 0.000 abstract description 2
- 230000000475 sunscreen effect Effects 0.000 abstract description 2
- 239000000516 sunscreening agent Substances 0.000 abstract description 2
- 235000010633 broth Nutrition 0.000 abstract 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 33
- 108090000193 Interleukin-1 beta Proteins 0.000 description 33
- 230000000694 effects Effects 0.000 description 25
- 238000011081 inoculation Methods 0.000 description 17
- 238000001514 detection method Methods 0.000 description 16
- 238000010586 diagram Methods 0.000 description 16
- 239000000284 extract Substances 0.000 description 15
- 102000003425 Tyrosinase Human genes 0.000 description 14
- 108060008724 Tyrosinase Proteins 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 230000008439 repair process Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 108090001007 Interleukin-8 Proteins 0.000 description 9
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 229960004441 tyrosine Drugs 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 244000293323 Cosmos caudatus Species 0.000 description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- PGNRLPTYNKQQDY-UHFFFAOYSA-N 2,3-dihydroxyindole Chemical compound C1=CC=C2C(O)=C(O)NC2=C1 PGNRLPTYNKQQDY-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 108010051081 dopachrome isomerase Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- -1 flavonoids compounds Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 210000004511 skin melanocyte Anatomy 0.000 description 1
- VBJGJHBYWREJQD-UHFFFAOYSA-M sodium;dihydrogen phosphate;dihydrate Chemical compound O.O.[Na+].OP(O)([O-])=O VBJGJHBYWREJQD-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present disclosure provides a preparation method of a phellinus baumii fermentation product, comprising: step one, activating, purifying and carrying out expanded culture treatment on Phellinus baumii to obtain a seed solution; inoculating the seed liquid to a fermentation substrate for fermentation culture treatment to obtain fermentation liquid; the fermentation substrate is potato homogenate added with pearl powder; and step three, performing separation treatment and sterilization treatment on the fermentation liquor to obtain supernatant. Also disclosed are Phellinus baumii fermentates made therefrom, including Phellinus baumii fermentation broths and dry powders thereof. The phellinus baumii is inoculated into potato homogenate and is fermented with pearls in a synergistic manner to prepare a fermented product with excellent anti-inflammatory performance and whitening performance, and the fermented product can be used as an effective component to be added into a cosmetic formula to prepare cosmetics such as a mask, essence, sunscreen cream, emulsion and the like.
Description
Technical Field
The disclosure belongs to the technical field of biological fermentation, and particularly relates to a new strain fermentation product of Phellinus baumii and a preparation method thereof.
Background
Phellinus baumii Pilat (Phellinus baumii Pilat.) commonly known as Phellinus linteus and Phellinus caryophyllus, belonging to Aphyllophorales, Polyporaceae, Phellinus. Phellinus baumii has strong decay force, and white decay of heartwood is caused. Phellinus baumii belongs to a perennial medicinal fungus, and was first collected in Li Shizhen Ben Cao gang mu. According to traditional Chinese medicine, Phellinus baumii is warm and mild in nature, bitter and pungent in taste, enters liver and bladder channels, and is used for treating metrorrhagia, bloody stranguria, rectocele and bloody diarrhea, leukorrhagia, amenorrhea, spleen deficiency and diarrhea and the like. A plurality of experimental researches show that polysaccharides and flavonoids compounds in Phellinus baumii have important biological activity and play an important role in treating cancers, protecting liver, enhancing immunity and repairing nerves.
However, the application of Phellinus baumii in cosmetics is still blank at present. The inventor finds that the fermentation product obtained by synergistic fermentation of Phellinus baumii and Margarita has excellent skin anti-inflammatory and repairing effects and whitening effect, and can be used as effective component for cosmetics.
Disclosure of Invention
The following presents a simplified summary of the disclosure in order to provide a basic understanding of some aspects of the disclosure. It should be understood that this summary is not an exhaustive overview of the disclosure. It is not intended to identify key or critical elements of the disclosure or to delineate the scope of the disclosure. Its sole purpose is to present some concepts in a simplified form as a prelude to the more detailed description that is discussed later.
In order to solve the technical problem, the technical scheme provided by the disclosure is as follows:
in a first aspect, the present disclosure provides a method for preparing a phellinus baumii fermentation product, comprising:
step one, activating, purifying and carrying out expanded culture treatment on Phellinus baumii to obtain a seed solution;
inoculating the seed liquid to a fermentation substrate for fermentation culture treatment to obtain fermentation liquid; the fermentation substrate is potato homogenate;
and step three, performing separation treatment and sterilization treatment on the fermentation liquor to obtain supernatant.
Further, in the preparation method of the Phellinus baumii fermented product, Phellinus baumii is a commercially available product, is purchased from China general microbiological culture Collection center, and can be CGMCC5.1265 or CGMCC 5.2061.
Further, in the preparation method of the phellinus baumii fermentation product, the hypha volume percentage of the seed liquid in the step one is more than 80%.
Further, in the above method for preparing a phellinus baumii fermentation product, the inoculation ratio of the phellinus baumii in the second step, that is, the volume ratio of the seed solution to the fermentation substrate is 1% to 10% (e.g., 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, etc.).
Further, in the preparation method of the Phellinus baumii fermented product, pearl powder is added into the fermentation substrate; the pearl powder content is 1-10 wt% (such as 2 wt%, 3 wt%, 4 wt%, 5 wt%, 6 wt%, 7 wt%, 8 wt%, 9 wt% etc.) of the potato homogenate; more preferably 1 to 5 wt% (e.g., 1.5 wt%, 2 wt%, 3 wt%, 4 wt%, 4.5 wt%, etc.).
Further, in the above method for preparing Phellinus baumii fermented product, the potato homogenate is obtained by homogenizing fresh potato pieces with water by a homogenizer and dissolving, wherein the potato content is 0.5-5 wt% (such as 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, 3 wt%, 3.5 wt%, 4 wt%, 4.5 wt%).
The fermentation substrate is subjected to conventional sterilization treatment, such as high temperature sterilization at 115 ℃ for 20min, prior to inoculation.
Further, in the above method for preparing a Phellinus baumii fermented product, the potato homogenate further comprises 0.3 wt% of monopotassium phosphate, 0.15 wt% of magnesium sulfate, 0.05 wt% of glucose, and 0.2 wt% of soybean peptide.
Further, in the above method for preparing Phellinus baumii fermentation product, the fermentation culture treatment temperature is 20-35 deg.C (such as 22 deg.C, 28 deg.C, 30 deg.C, 32 deg.C, 34 deg.C, etc.), and the time is 48-96h (such as 52h, 60h, 72h, 84h, 88h, 92h, etc.).
Further, the fermentation culture treatment is carried out in a shaking table at a rotation speed of 100r/min to 200r/min (e.g., 110r/min, 120r/min, 130r/min, 140r/min, 150r/min, 160r/min, 170r/min, 180r/min, 190r/min, 195r/min, etc.).
Further, in the above method for preparing a fermentation product of Phellinus baumii, the separation treatment is performed by centrifugation; more preferably, the centrifugation speed is 4500r/min-5500r/min (such as 4600r/min, 4800r/min, 5000r/min, 5200r/min, 5400r/min, etc.), and the centrifugation time is 10min-20min (such as 12min, 15min, 18min, etc.).
In a second aspect, the present disclosure provides a phellinus baumii fermentation product prepared by the above preparation method. The Phellinus baumii fermentation product comprises Phellinus baumii fermentation broth and dry powder thereof, and the dry powder can be prepared by freeze drying or spray drying.
In a third aspect, the present disclosure also provides a cosmetic containing the aforementioned phellinus baumii fermentation product. The cosmetic can be facial mask, essence, cream, lotion, etc.
Compared with the prior art, the beneficial effects of the present disclosure include but are not limited to:
1. the Phellinus baumii is inoculated into potato homogenate and is fermented with pearls in a synergistic manner to prepare a fermented product with excellent anti-inflammatory performance and whitening performance, and the fermented product can be used as an effective component to be added into a cosmetic formula to prepare cosmetics such as a mask, essence, sunscreen cream, emulsion and the like;
2. the Phellinus baumii fermentation product provided by the disclosure as a cosmetic efficacy component has the characteristics of strong efficacy, low cost, simple operation, greenness, safety and the like, and has strong practicability and popularization value.
Drawings
FIG. 1 is a schematic diagram of the detection results of the anti-inflammatory effect of the protection treatment of Phellinus baumii fermentation in example 2, indexes: IL-1 β;
fig. 2 is a schematic diagram of the anti-inflammatory effect test results of the protection treatment of the pearl potato extract in example 2, with the following indexes: IL-1 beta;
FIG. 3 is a schematic diagram of the detection results of the anti-inflammatory effect of the protection treatment of Phellinus baumii fermentation products with different concentrations in example 2, and the indexes are as follows: IL-1 β;
FIG. 4 is a schematic diagram of the detection result of the anti-inflammatory effect of the repair treatment of Phellinus baumii fermentation product in example 2, with the following indexes: IL-1 β;
fig. 5 is a schematic diagram of the detection result of the repair treatment anti-inflammatory effect of the pearl potato extract in example 2, and indexes are as follows: IL-1 β;
FIG. 6 is a schematic diagram of the detection results of the repair treatment anti-inflammatory effects of different concentrations of Phellinus baumii fermentation in example 2, with the following indexes: IL-1 β;
fig. 7 is a schematic diagram of the detection result of the repair treatment anti-inflammatory effect of the pearl and potato extract in example 2, and the indexes are as follows: IL-8;
FIG. 8 is a schematic diagram of the detection results of the anti-inflammatory effects of the repair treatment of Phellinus baumii fermentation products with different concentrations in example 2, and the indexes are as follows: IL-8.
Detailed Description
The following examples further illustrate the present invention but are not to be construed as limiting the invention. Modifications or substitutions to methods, steps or conditions of the present invention may be made without departing from the spirit and substance of the invention.
The technical solutions of the present disclosure will be described below with reference to exemplary embodiments. The experimental procedures used in the following examples are all conventional procedures unless otherwise specified. Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
In the examples, Phellinus baumii is a commercially available product, purchased from China general microbiological culture Collection center, and the preservation numbers are: CGMCC 5.2061.
Example 1 Phellinus baumii fermentation experiment to prepare fermented product of Margarita
(1) Activating strains: a colony is selected from a preserved Phellinus baumii CGMCC5.2061 (laboratory number of 6984, the strain is marked by the laboratory number in the following) inclined plane and is placed in a glucose potato agar culture medium for culturing for 7 days for activation at 28 ℃, then the obtained single colony is inoculated into 100mL of glucose potato liquid culture medium for culturing for 7 days at 28 ℃ and 180rpm, and ganoderma lucidum liquid is obtained, wherein the volume ratio of the mycelium accounts for 80 percent of the whole seed liquid.
(2) Preparing a fermentation substrate: adding pearl powder into potato homogenate according to the setting of table 1 in a certain mass ratio (1-10 wt%, such as 1 wt%, 5 wt%, 10 wt%); potato homogenate is prepared by adding 1000ml mineral water (containing 0.3% potassium dihydrogen phosphate, 0.15% magnesium sulfate, 0.05% glucose, and 0.2% soybean peptide) into 20g potato pieces, homogenizing in a homogenizer, dissolving, and packaging. The fermentation substrate is sterilized prior to inoculation.
(3) Inoculating and shaking bacteria: according to the inoculation amount of 5 percent by volume, 5mL of the seed solution is inoculated into a 250mL triangular flask filled with 100mL of liquid fermentation medium and fermented in a shaking table at the rotating speed of 180r/min, the culture temperature of 28 ℃ and the fermentation time of 48 hours.
(4) Centrifuging: centrifuging the fermentation broth at 4800r/min for 10min, collecting supernatant, and sterilizing to obtain sample numbers shown in Table 1.
This example also included a control group, which was a 2% potato homogenate on a simple fermentation substrate, to which was added 0.3% monopotassium phosphate, 0.15% magnesium sulfate, 0.05% glucose, and 0.2% soybean peptide. See table 1 for details:
TABLE 1 fermentation System and Experimental group designations of example 1
Number of experimental group | Fermentation substrate | Inoculation situation |
TD-0 | Substrate for simple fermentation | Without inoculation |
TD-6984 | Substrate for simple fermentation | Inoculation of 6984 |
1%ZZ-TD-6984 | Fermentation substrate containing 1% of pearl powder | Inoculation of 6984 |
5%ZZ-TD-6984 | Fermentation substrate containing 5% of pearl powder | Inoculation of 6984 |
10%ZZ-TD-6984 | Fermentation substrate containing 10% of pearl powder | Inoculation of 6984 |
1%ZZ-TD | Fermentation substrate containing 1% of pearl powder | Without |
5%ZZ-TD | Fermentation substrate containing 5% of pearl powder | Without |
10%ZZ-TD | Fermentation substrate containing 10% of pearl powder | Without inoculation |
The main components of the product prepared in example 1, including protein, amino acid and calcium content, were measured, and the results are shown in tables 2 to 4 below.
TABLE 2 amino acid content (umol/mL) of the stock solution or fermentation stock solution samples
TABLE 3 protein content (ug/mL) of the stock or fermentation stock samples
TABLE 4 calcium content of stock solution or fermentation stock solution
Number of experimental group | Calcium (mg/kg) | Experiment group number | Calcium (mg/kg) |
TD-0 | 12.4 | TD-6984 | 5.9 |
1%ZZ-TD | 39.0 | 1%ZZ-TD-6984 | 57.2 |
5%ZZ-TD | 33.1 | 5%ZZ-TD-6984 | 41.1 |
10%ZZ-TD | 28.2 | 10%ZZ-TD-6984 | 22.5 |
Example 2 efficacy analysis of Phellinus baumii fermentation
Toxicity and protective action of Phellinus baumii fermentation product on human skin fibroblast (HSF cell)
1. Establishment of oxidative stress model
HSF cells were plated at 1X 10 per well4Inoculating into 96-well plate, culturing overnight in cell culture box, removing culture medium, adding 100 μ L of different concentrations of H2O2(50~1000μmol·L-1) The culture medium of (1) was repeated 5 times for each group, and no H was added to the control group2O2. After 1, 2, 3, 4h of stimulation, the OD of each well was measured at 490nm using the MTT method. Obtaining the survival rate of HSF cells (see figure 1), and selecting hydrogen peroxide with the cell survival rate of 50 percentThe degree serves as a modeling concentration. In this example, 100. mu. mol. L-1H of (A) to (B)2O2The HSF cells are treated for 2h for modeling, and the cell survival rate is (49.74 +/-2.99)%.
2. Sample pair H2O2Protection and repair testing of induced oxidative stress model
HSF cells were plated at 1X 10 per well4Each of the cells was inoculated in a 96-well plate and cultured overnight in a cell incubator, and a blank Control group (Control), a Model group (Model), and each sample group (stock solution or fermentation stock solution in example 1) were set for each experiment, and 3 replicates were set for each group.
The protection effect detection means that after the sample acts on the cells, the cells are damaged again, the secretion of IL-1 beta and the like of the cells is observed, and whether the sample has the protection effect or not is judged. Protection processing group in this embodiment: adding the sample to culture for 24H, and adding H2O2And (5) stimulating for 2 h.
The detection of the repairing effect means that after the cells are damaged, the samples are used for acting, and whether the samples have the repairing effect is evaluated by measuring the content of IL-1 beta and the like. The repair treatment group in this embodiment: adding H first2O2After 2h of stimulation, 100. mu.L of sample was added to each well and incubated for 24 h.
Testing indexes are as follows: IL-1. beta. and IL-8 (test method refers to kit instructions). The results are shown in FIGS. 1-8.
FIG. 1 is a schematic diagram of the anti-inflammatory effect detection result of the protection treatment of Phellinus baumii pearl fermentation in example 2, and the indexes are as follows: IL-1 beta. From the figure, it can be seen that the IL-1 beta of the model group is extremely higher than that of the blank control group, which indicates that the model is successfully established, 10% ZZ-TD has no significant difference compared with the model group, after inoculation, 10% ZZ-TD-6985 is extremely lower than that of the model group, which indicates that the fermentation liquor after 6984 inoculation has the functions of reducing the secretion of IL-1 beta and resisting inflammation.
Fig. 2 is a schematic diagram of the anti-inflammatory effect test results of the protection treatment of the pearl potato extract in example 2, with the following indexes: IL-1 beta. From the figure, it can be seen that the IL-1 beta of the model group is significantly higher than that of the blank control group, which indicates that the model is successfully established, and the influence change difference of the pearl and potato extracts with different proportions on the IL-1 beta is large: when the pearl ratio is 0, the effect of reducing IL-1 beta is not achieved; the pearl and potato extract added with 1-5% of pearl powder has very obvious IL-1 beta reducing effect, which shows anti-inflammatory effect, and when the pearl addition proportion is increased to 10%, the pearl and potato extract has no obvious difference on the influence of IL-1 beta and has no anti-inflammatory effect.
FIG. 3 is a schematic diagram of the detection results of the protection treatment anti-inflammatory effect of the Phellinus baumii pearl fermentation products with different concentrations in example 2, and the indexes are as follows: IL-1 beta. From the figure, the IL-1 beta of the model group is remarkably higher than that of a blank control group, the model is successfully established, and the secretion of the IL-1 beta cannot be reduced by a fermentation product obtained by inoculating Phellinus baumii 6983 into a potato culture medium without pearl addition, and the fermentation product has no anti-inflammatory effect; but inoculation with phellinus baumii 6984 can reduce IL-1 β very significantly when 10% pearls are added in proportion.
FIG. 4 is a schematic diagram of the detection result of the repair treatment anti-inflammatory effect of the Phellinus baumii pearl fermentation product in example 2, and the indexes are as follows: IL-1 beta. It can be seen from the figure that the model group IL-1 beta is significantly higher than that of the blank control group, which indicates that the model is successfully established, and the effects of the potato extract with the same pearl addition ratio on IL-1 beta before and after fermentation are compared, and it can be seen that the fermentation product obtained after inoculation of Phellinus baumii 6983 does not have the effect of significantly reducing IL-1 beta compared with the fermentation product before.
Fig. 5 is a schematic diagram of the detection result of the repair treatment anti-inflammatory effect of the pearl potato extract in example 2, and indexes are as follows: IL-1 beta. It can be seen from the figure that the IL-1 beta of the model group is extremely higher than that of the blank control, which shows that the model is successfully established, the pearl and potato extract with the pearl addition ratio of 5% has a repairing effect, and the pearl and potato extract with the pearl addition ratio of 1% and the pearl addition ratio of 10% has no reduction effect on the IL-1 beta.
FIG. 6 is a schematic diagram of the detection results of the repair treatment anti-inflammatory effect of the Phellinus baumii pearl fermentation products with different concentrations in example 2, and the indexes are as follows: IL-1 beta. The graph shows that the IL-1 beta of the model group is extremely higher than that of the blank control group, which shows that the model is successfully established, and the secretion of the IL-1 beta can not be reduced in the potato culture medium without pearl addition no matter before or after fermentation, and the potato culture medium has no anti-inflammatory effect; the fermentation broth obtained after the fermentation of the potato extract added with the pearl does not have the function of reducing IL-1 beta.
Fig. 7 is a schematic diagram of the detection result of the repair treatment anti-inflammatory effect of the pearl and potato extract in example 2, and the indexes are as follows: IL-8. It can be seen from the figure that the IL-8 of the model group is significantly higher than that of the blank control group, which shows that the model is successfully established, the pearl and potato extract with 10 percent of pearl addition has the effect of reducing IL-8, namely has the restoration effect, but the potato extract with 1 percent of pearl addition and 5 percent of pearl addition has no anti-inflammation effect.
FIG. 8 is a schematic diagram of the detection results of the repair treatment anti-inflammatory effect of the Phellinus baumii pearl fermentation products with different concentrations in example 2, and the indexes are as follows: IL-8. From the figure, it can be seen that the IL-8 of the model group is extremely higher than that of the blank control group, which shows that the model is successfully established, and the secretion of IL-1 beta cannot be reduced by the potato fermentation liquid without pearl addition fermented by Phellinus baumii 6984, which shows that the potato fermentation liquid has no anti-inflammatory effect; and the potato fermentation liquor with the pearl addition of 1-10% has the effect of reducing IL-8, which shows that the potato fermentation liquor has a repairing effect.
Second, Phellinus baumii pearl fermentation product tyrosinase inhibition activity test
1. Principle of experiment
The formation of melanin is that tyrosine in skin melanocyte tissue is gradually converted into true melanin through intermediates such as dopa, dopaquinone, dopachrome and dihydroxyindole under the action of enzymes such as tyrosinase and the like; furthermore, the melanocyte tissue transfers melanin into keratin cells and is shed along with the turnover of the stratum corneum, the difference of human skin color mainly depends on the content and distribution of the true melanin and the pheomelanin, but when the true melanin is excessively increased and unevenly distributed, local skin over-blacking or pigmentation is caused. There are three major enzymes involved in melanin synthesis: tyrosinase, dopachrome tautomerase and dihydroxyindole carboxylate oxidase. Tyrosinase belongs to oxidoreductase, is the main rate-limiting enzyme for melanin synthesis, the activity of the oxidoreductase determines the amount of melanin formed, and many whitening and freckle removing products sold on the market at present achieve the whitening effect by inhibiting the activity of tyrosinase, so the strength of the tyrosinase inhibition effect is the main index for evaluating whitening cosmetics. The L-tyrosinase and its substrate L-tyrosine can be reacted catalytically. After a reagent with the effect of inhibiting the activity of the L-tyrosinase is added into an experimental system, the inhibition effect on the catalytic reaction can be generated, and the inhibition rate of the reagent on the activity of the L-tyrosinase can be evaluated by measuring the absorbance at 475nm before and after the reagent is added.
2. Preparation of the experiment
1) PBS phosphate buffer (pH 6.8): dissolving 17.91g of dodecahydrate disodium hydrogen phosphate in distilled water, and dissolving in 500 mL; dissolving 7.8g of dihydrate sodium dihydrogen phosphate in distilled water, and dissolving in 500 mL; the two solutions, 92.6mL and 107.4mL, were combined to 200mL of PBS phosphate buffer, pH 6.8.
2)0.1mol/L hydrochloric acid solution: 0.862mL of HCl solution with HCl content of 36% -38% and distilled water to 100 mL.
3) 0.05% L-tyrosine solution: 0.05g L-tyrosine was dissolved in 35mL of 0.1mol/L HCl solution, and then 65mL of PBS phosphate buffer (pH6.8) was added thereto to make 100 mL.
4) Tyrosinase solution: diluting the tyrosinase powder with PBS buffer solution to obtain tyrosinase solution with enzyme activity of 100U/mL.
3. Experimental procedure
1) After the C2 pipe is well prepared and shaken up, the mixture is heated in a water bath kettle at 37 ℃ for 10min, and the zero setting is carried out under the wavelength of 475 nm.
2) Mixing the solution in a C1 tube, shaking, performing water bath at 37 ℃ for 10min, adding 1ml of tyrosinase, continuing the water bath for 10min, and determining the absorbance value of C1.
3) The absorbance values of T1 were determined by zeroing with T2 in the same manner as in 1) and 2).
4) And calculating the tyrosinase activity inhibition rate T (%) of the raw liquid or fermentation raw liquid sample.
TABLE 5 tyrosinase inhibition ratio test reagent proportioning table
Numbering | L-tyrosine | Sample (I) | PBS | Tyrosinase enzyme | Total volume |
C1 | 2mL | —— | 4mL | 1mL | 7ml |
C2 | 2mL | —— | 5ml | —— | 7ml |
T1 | 2ml | 2mL | 2mL | 1mL | 7ml |
T2 | 2ml | 2ml | 3ml | —— | 7ml |
4. Data processing
The formula: t (%) - (C1-T1)/C1 × 100%. The results are shown in Table 6, and the data in the table show that Phellinus baumii and Margarita have synergistic effect and remarkably improve the whitening performance of the fermented product.
TABLE 6 tyrosinase inhibition test results
Finally, it is further noted that, in the present disclosure, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising an … …" does not exclude the presence of other identical elements in the process, method, article, or apparatus that comprises the element.
While the disclosure has been disclosed above by the description of specific embodiments thereof, it should be understood that various modifications, improvements or equivalents of the disclosure may be devised by those skilled in the art within the spirit and scope of the appended claims. Such modifications, improvements and equivalents are intended to be included within the scope of the present disclosure as claimed.
Claims (10)
1. A preparation method of a Phellinus baumii fermentation product is characterized by comprising the following steps:
step one, activating, purifying and carrying out expanded culture treatment on Phellinus baumii to obtain a seed solution;
inoculating the seed liquid to a fermentation substrate for fermentation culture treatment to obtain fermentation liquid; the fermentation substrate is potato homogenate added with pearl powder;
and step three, performing separation treatment and sterilization treatment on the fermentation liquor to obtain supernatant.
2. The method of preparing a phellinus baumii fermentation product according to claim 1, wherein the phellinus baumii is selected from at least one of the following: CGMCC5.1265 and CGMCC 5.2061.
3. The method for producing a Phellinus baumii fermented product according to claim 1 or 2, wherein in the first step, the volume percentage of hyphae in the seed solution is 80% or more.
4. The method for preparing a Phellinus baumii fermented product according to any of claims 1-3, wherein the volume ratio of the seed liquid to the fermentation substrate in step two is 1% -10%.
5. The method for preparing Phellinus baumii fermented product according to any of claims 1-4, wherein the content of pearl powder is 1-10 wt% of potato homogenate; preferably 1 to 5 wt%.
6. The method of preparing a Phellinus baumii fermented product according to any one of claims 1-5, wherein the potato homogenate is prepared by homogenizing fresh potato pieces with water in a homogenizer and dissolving, wherein the content of potato is 0.5-5 wt%.
7. The method for preparing Phellinus baumii fermentation product according to any of claims 1-6, wherein the potato homogenate further comprises 0.3 wt% potassium dihydrogen phosphate, 0.15 wt% magnesium sulfate, 0.05 wt% glucose, and 0.2 wt% soybean peptide.
8. The method for preparing Phellinus baumii fermentation product according to any of claims 1-6, wherein the temperature of fermentation culture treatment in step two is 20-35 deg.C, and the time is 48-96 h; preferably, the fermentation culture treatment is carried out in a shaking table, wherein the rotation speed of the shaking table is 100r/min-200 r/min.
9. The method for producing a Phellinus baumii fermented product according to any one of claims 1-6, wherein the separation treatment in step three is performed by centrifugation; more preferably, the centrifugal speed is 4500r/min-5500r/min, and the centrifugal time is 10min-20 min.
10. A phellinus baumannii fermented product prepared by the preparation method according to any one of claims 1 to 9, which comprises a phellinus baumannii fermented liquid and its dry powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210049427.5A CN114533633B (en) | 2022-01-17 | 2022-01-17 | Phellinus baumii ferment and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210049427.5A CN114533633B (en) | 2022-01-17 | 2022-01-17 | Phellinus baumii ferment and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114533633A true CN114533633A (en) | 2022-05-27 |
CN114533633B CN114533633B (en) | 2024-02-27 |
Family
ID=81670728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210049427.5A Active CN114533633B (en) | 2022-01-17 | 2022-01-17 | Phellinus baumii ferment and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114533633B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208954A (en) * | 2020-09-07 | 2021-08-06 | 北京工商大学 | Anti-inflammatory and anti-aging ganoderma lucidum composite fermentation product and preparation method and application thereof |
-
2022
- 2022-01-17 CN CN202210049427.5A patent/CN114533633B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208954A (en) * | 2020-09-07 | 2021-08-06 | 北京工商大学 | Anti-inflammatory and anti-aging ganoderma lucidum composite fermentation product and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
吴希美等: "可溶性珍珠粉和珍珠粉的抗炎作用比较", 中国药理学会通讯, vol. 17, no. 4, pages 50 * |
杜桂艳等: "鲍氏层孔菌瓶栽生产技术", 中国食用菌, vol. 24, no. 4, pages 27 - 28 * |
王一菲等: "栎生桑黄和忍冬桑黄液体培养过程中发酵液抗氧化能力", 研究论文, vol. 38, no. 6, pages 938 - 950 * |
Also Published As
Publication number | Publication date |
---|---|
CN114533633B (en) | 2024-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109939027B (en) | Method for preparing ergothioneine-containing cosmetic stock solution by fermenting hericium erinaceus | |
KR101375775B1 (en) | Functional cosmetic materials using Wax Gourd and The Manufacturing Method | |
CN113337545B (en) | Schizophyllum commune fermentation product, preparation method thereof, skin care product and schizophyllum commune culture medium | |
KR20080094458A (en) | Anti-wrinkle cosmetic composition | |
CN109528568A (en) | A kind of composition and preparation method thereof with anti-aging and white-skinned face function | |
CN103263448B (en) | Fermentation bacteria used for fermentation pretreatment to improve extraction of Ginkgo biloba L. leaf flavone and application | |
KR20100114673A (en) | The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe | |
KR20080094456A (en) | Whitening cosmetic composition | |
KR20080094455A (en) | Whitening cosmetic composition | |
CN109694886A (en) | A kind of green tea fermentation filtrate and its preparation method and application | |
CN113842347B (en) | Composition of black rose lucid ganoderma ferment and black rose enzymatic hydrolysate with anti-aging and whitening activities | |
KR100438009B1 (en) | A cosmetic composition containing an extract of Grifola frondosa | |
CN113842341B (en) | Roselle fermentation product and preparation method and application thereof | |
KR101685579B1 (en) | Method for manufacturing skin-whitener composition containing Thuja orientalis and skin-whitener composition prepared therefrom | |
CN112691125B (en) | Pharmaceutical composition for whitening or resisting aging, preparation method thereof and skin care product | |
CN112370390B (en) | Fermentation liquor for resisting aging, removing wrinkles and repairing skin barrier and preparation method thereof | |
CN104644538B (en) | Radix scutellariae lactobacillus fermentation, the cosmetics containing fermentate and preparation method and purposes | |
KR20090002679A (en) | Whitening cosmetic composition | |
CN114533633A (en) | Phellinus baumii fermentation product and preparation method thereof | |
CN113827523B (en) | Rose composition and application thereof | |
CN114699343B (en) | Phellinus linteus fermentation product and preparation method thereof | |
KR100302505B1 (en) | Fermented product using lactic acid bacteria and cosmetic composition | |
CN111374922B (en) | Rice composite fermentation product and preparation method and application thereof | |
CN108420074A (en) | A kind of tyrosinase activity inhibitor and its application | |
CN114099378A (en) | Preparation method of natural antioxidant spot-removing and spot-lightening skin care lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |